EUVIMEDOpdag EUVIMED
Multizentrische StudieBeobachtungsstudie

Drug‐Coated Balloon‐Based Treatment of Left Main True Bifurcation Lesion

Ae-Young Her iD, Tae Hyun Kim, Eun-Seok Shin iD, Sunwon Kim iD, Bitna Kim iD, Yong Hoon Kim iD, Ki Hong Choi, Yun-Kyeong Cho, Hyun-Jong Lee iD, Young Bin Song iD, Chang-Wook Nam, Hyeon-Cheol Gwon

Catheterization and Cardiovascular Interventions · 2025-04 · 105 (5) · 1024-1031

DOI: 10.1002/ccd.31416 ↗

At a glance

Multizentrische Studie in Catheterization and Cardiovascular Interventions, published online on 2025-01-22. Written by Ae-Young Her and 11 co-authors. Institution: Division of Cardiology, Department of Internal Medicine, Kangwon National University College of Medicine, Kangwon National University School of Medic…. Major MEDLINE topics: Angioplasty, Balloon, Coronary, Cardiac Catheters, Cardiovascular Agents, Coated Materials, Biocompatible. Cited 7 times so far (Crossref); 32 references. Funded by: The authors received no specific funding for this work..

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

There is a paucity of data regarding drug‐coated balloon (DCB) treatment in the context of left main (LM) true bifurcation lesions.

Aims

The aim of this study was to evaluate the safety and efficacy of DCB‐based treatment for unprotected LM true bifurcation lesions.

Methods

A total of 39 patients with LM true bifurcation lesion (Medina: 1,1,1/0,1,1/1,0,1) who were successfully treated with DCB alone or in combination with drug‐eluting stent (DES) were retrospectively enrolled into the DCB‐based group. They were compared with 39 propensity‐matched patients who were treated with second‐generation DES from the COBIS III registry ( n = 2648). Major adverse cardiovascular events (MACE) were defined as cardiac death, myocardial infarction, stent or target lesion thrombosis, and target lesion revascularization at the 2‐year follow‐up.

Results

Baseline clinical characteristics were similar between the groups, except for the prevalence of in‐stent restenosis (ISR) lesions (41.0% in DCB‐based group vs. 17.9% in DES‐only group, p = 0.047). In the DCB‐based group, 59.0% of the patients ( n = 23) underwent DCB‐only treatment. There were no cases of abrupt vessel closure requiring treatment following DCB application. The MACE were comparable between both groups (12.8% in DCB‐based group vs. 17.9% in DES‐only group, p = 0.861) after 2 years.

Conclusions

In patients with unprotected LM true bifurcation lesions, DCB‐based treatment demonstrated comparable clinical outcomes at the 2‐year follow‐up when compared to DES‐only treatment. DCB‐based treatment could be considered a safe and effective alternative to DES for carefully selected patients who have achieved satisfactory predilation results (Impact of DCB Treatment in De Novo Coronary Lesion; NCT04619277).

Subjects

MeSH terms (MEDLINE)

Angioplasty, Balloon, CoronaryCardiac CathetersCardiovascular AgentsCoated Materials, BiocompatibleCoronary Artery DiseaseAgedFemaleHumansMaleMiddle AgedDrug-Eluting StentsProsthesis DesignRegistriesRetrospective StudiesRisk FactorsTime FactorsTreatment Outcome

Author keywords

angioplastyballooncoronary artery diseasepercutaneous coronary intervention

Substances

Cardiovascular AgentsCoated Materials, Biocompatible

Authors and institutions

  • Division of Cardiology, Department of Internal Medicine, Kangwon National University College of Medicine, Kangwon National University School of Medicine, Chuncheon, South Korea.
  • Department of Cardiology, Ulsan Medical Center, Ulsan, South Korea.
  • Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
  • Department of Cardiology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan-si, South Korea.
  • Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, South Korea.
  • Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, South Korea.

ORCID profiles: Ae-Young Her, Eun-Seok Shin, Sunwon Kim, Bitna Kim, Yong Hoon Kim, Hyun-Jong Lee, Young Bin Song

Funding

  • The authors received no specific funding for this work.

Cite

APA

Her, A. Y., Kim, T. H., Shin, E. S., Kim, S., Kim, B., Kim, Y. H., Choi, K. H., Cho, Y. K., Lee, H. J., Song, Y. B., Nam, C. W., & Gwon, H. C. (2025). Drug‐Coated Balloon‐Based Treatment of Left Main True Bifurcation Lesion. Catheterization and Cardiovascular Interventions, 105(5), 1024-1031. https://doi.org/10.1002/ccd.31416

Vancouver

Her AY, Kim TH, Shin ES, Kim S, Kim B, Kim YH, et al. Drug‐Coated Balloon‐Based Treatment of Left Main True Bifurcation Lesion. Catheterization and Cardiovascular Interventions. 2025;105(5):1024-1031. doi:10.1002/ccd.31416

BibTeX
@article{Her2025,
  author = {Her, Ae-Young and Kim, Tae Hyun and Shin, Eun-Seok and Kim, Sunwon and Kim, Bitna and Kim, Yong Hoon and Choi, Ki Hong and Cho, Yun-Kyeong and Lee, Hyun-Jong and Song, Young Bin and Nam, Chang-Wook and Gwon, Hyeon-Cheol},
  title = {Drug‐Coated Balloon‐Based Treatment of Left Main True Bifurcation Lesion},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  volume = {105},
  number = {5},
  pages = {1024--1031},
  doi = {10.1002/ccd.31416}
}
Start for free →